281
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies

, , & ORCID Icon
Pages 1579-1587 | Received 03 Jan 2020, Accepted 19 Feb 2020, Published online: 04 Mar 2020

Reference

  • Aubol, B. E., Chakrabarti, S., Ngo, J., Shaffer, J., Nolen, B., Fu, X.-D., … Adams, J. A. (2003). Processive phosphorylation of alternative splicing factor/splicing factor 2. Proceedings of the National Academy of Sciences of Sciences of the United States of America, 100(22), 12601–12606. doi:10.1073/pnas.1635129100
  • Baskaran, K., Duarte, J. M., Biyani, N., Bliven, S., & Capitani, G. (2014). A PDB-wide, evolution-based assessment of protein – protein interfaces. BMC structural biology, 14, 22. doi:10.1186/s12900-014-0022-0.
  • Bullock, N., & Oltean, S. (2017). The many faces of SRPK1. Journal of Pathology, 241(4), 437–440. doi:10.1002/path.4846.
  • Bullock, N., Potts, J., Simpkin, A. J., Koupparis, A., Harper, S. J., Oxley, J., & Oltean, S. (2016). Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion. Journal of Clinical Pathology, 69(2), 171–175. doi:10.1136/jclinpath-2015-203125
  • Chetri, P. B., Shukla, R., & Tripathi, T. (2019). Identification and characterization of glyceraldehyde 3-phosphate dehydrogenase from Fasciola gigantica. Parasitology Research, 118(3), 861–872. doi:10.1007/s00436-019-06225-w
  • De Miguel, F. J., Sharma, R. D., Pajares, M. J., Montuenga, L. M., Rubio, A., & Pio, R. (2014). Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. Cancer Research, 74(4), 1105–1115. doi:10.1158/0008-5472.CAN-13-1481
  • Goyal, N., Chandra, A., Qamar, I., & Singh, N. (2019). Structural studies on dihydrouridine synthase A (DusA) from Pseudomonas aeruginosa. International Journal of Biological Macromolecules, 132, 254–264. doi:10.1016/j.ijbiomac.2019.03.209
  • Gui, J. F., Lane, W. S., & Fu, X. D. (1994). A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature, 369(6482), 678–682. doi:10.1038/369678a0
  • Gupta, P., Mohammad, T., Khan, P., Alajmi, M. F., Hussain, A., Rehman, M. T., & Hassan, M. I. (2019). Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy. Biomedicine & Pharmacotherapy, 118, 10924. doi:10.1016/j.biopha.2019.109245
  • Hayes, G. M., Carrigan, P. E., Beck, A. M., & Miller, L. J. (2006). Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Research, 66(7), 3819–3827. doi:10.1158/0008-5472.CAN-05-4065
  • Huang, Y.-Q., Ling, X.-H., Yuan, R.-Q., Chen, Z.-Y., Yang, S.-B., Huang, H.-X., … Qiu, S.-P. (2017). miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein. Molecular Medicine Reports, 16(3), 2431–2438. doi:10.3892/mmr.2017.6910
  • Kataoka, N., Bachorik, J. L., & Dreyfuss, G. (1999). Transportin-SR, a nuclear import receptor for SR proteins. The Journal of Cell Biology, 145(6), 1145-1152. doi:10.1083/jcb.145.6.1145
  • Ma, C. T., Ghosh, G., Fu, X. D., & Adams, J. A. (2010). Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1. Journal of Molecular Biology, 403(3), 386–404. doi:10.1016/j.jmb.2010.08.024
  • Misteli, T., & Spector, D. L. (1998). The cellular organization of gene expression. Current Opinion in Cell Biology, 10(3), 323–331. doi:10.1016/S0955-0674(98)80007-0
  • Ngo, J. C. K., Giang, K., Chakrabarti, S., Ma, C.-T., Huynh, N., Hagopian, J. C., … Ghosh, G. (2008). A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Molecular Cell, 29(5), 563–576. doi:10.1016/j.molcel.2007.12.017
  • Ngo, J. C. K., Gullingsrud, J., Giang, K., Yeh, M. J., Fu, X.-D., Adams, J. A., … Ghosh, G. (2007). SR protein kinase 1 is resilient to inactivation. Structure, 15(1), 123–133. doi:10.1016/j.str.2006.11.011
  • Nikas, I. P., Themistocleous, S. C., Paschou, S. A., & Tsamis, K. I. (2019). Serine-arginine protein kinase 1 (SRPK1) as a prognostic factor and potential therapeutic target in cancer: Current evidence and future perspectives. Cells, 1, 1–21. doi:10.3390/cells9010019
  • Odunsi, K., Mhawech-Fauceglia, P., Andrews, C., Beck, A., Amuwo, O., Lele, S., … Huang, R.-Y. (2012). Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in cisplatin cytotoxicity in vitro. PLoS One, 7(12), e51030. doi:10.1371/journal.pone.0051030
  • Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera–A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. doi:10.1002/jcc.20084
  • Rajendran, V., Shukla, R., Shukla, H., & Tripathi, T. (2018). Structure-function studies of the asparaginyl-tRNA synthetase from Fasciola gigantica: Understanding the role of catalytic and non-catalytic domains. Biochemical Journal, 475(21), 3377–3391. doi:10.1042/BCJ20180700
  • Shukla, R., & Singh, T. R. (2019). Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics, 38(1), 248-262. doi:10.1080/07391102.2019.1571947
  • Talele, T. T., & McLaughlin, M. L. (2008). Molecular docking/dynamics studies of Aurora A kinase inhibitors. Journal of Molecular Graphics and Modelling, 26(8), 1213–1222. doi:10.1016/j.jmgm.2007.11.003
  • Touw, W. G., Vriend, G., & Berghuis, A. (2014). BDB: Databank of PDB files with consistent B-factors. Protein Engineering, Design and Selection, 27(11), 457–462. doi:10.1093/protein/gzu044.
  • Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. 10.1002/jcc.20291 16211538
  • van Roosmalen, W., Le Dévédec, S. E., Golani, O., Smid, M., Pulyakhina, I., Timmermans, A. M., … van de Water, B. (2015). Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. Journal of Clinical Investigation, 125(4), 1648–1664. doi:10.1172/JCI74440

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.